Page results
-
Autoimmune serology is provided for: Connective tissue diseases, Endocrine diseases, Liver diseases, Rheumatic diseases, Skin diseases, Thyroid diseases.
-
The department has a special interest in sexually transmitted viral infections and viral infections in relation to hepatitis, bone marrow transplants and HIV-related viral resistance.
-
The day surgery unit, comprises of two operating theatres and a ward located on level T2 at University College Hospital.
-
Sterile services provides a complete decontamination service for medical devices.
-
Advice for University College London Hospital patients who have experienced hair loss.
-
This is a unique service screening women at risk of ovarian cancer due to a strong family history.
-
Diet and nutrition advice for people experiencing weight loss, weight gain, appetite changes, difficulty eating, or other digestive problems which have happened as a result of their treatment or condition. Advice is also available for people who are confused about what diet or nutrition advice to follow.
-
We run two separate Urogynaecology services at UCH: the Urogynaecology and Pelvic Floor Unit and the Female Pelvic Medicine and Reconstructive Surgery Unit.
-
This page gives advice for those wanting to refer patients for nuclear medicine investigations at University College London Hospitals NHS Foundation Trust. Given at the end of this page are appropriate referral guidelines for the tests we perform.
-
At your first visit to UCLH your midwife will discuss birth place options with you and recommend a place of birth.
File results
-
NIHR Patient Research Experience Survey 2022-2023
-
FOI201790 Complementary and Alternative Medicine Library and Information Service refurbishment
-
FOI2017119 Diagnosis and treatment of Alzheimer disease patients
-
FOI/2023/0594 - Asthma Treatment
-
FOI2017117 Freedom of Information Act requests
-
FOI2017115 Publications relating to learning from complaints, claims, incidents, serious incidents, events and inquests
-
FOI2017110 DNRs placed upon patients
-
FOI/2023/0614 - Communications
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)